CARECLOUD INC - MTBC 11 PERP (MTBCP) Fundamental Analysis & Valuation

NASDAQ:MTBCP • US14167R2094

26.9137 USD
-0.08 (-0.28%)
Last: Jan 9, 2023, 08:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MTBCP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

MTBCP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. The financial health of MTBCP is average, but there are quite some concerns on its profitability. While showing a medium growth rate, MTBCP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. MTBCP Profitability Analysis

1.1 Basic Checks

  • MTBCP had negative earnings in the past year.
  • In the past year MTBCP had a positive cash flow from operations.
MTBCP Yearly Net Income VS EBIT VS OCF VS FCFMTBCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M -20M

1.2 Ratios

  • MTBCP has negative profitability rations, so we won't be analyzing them here.
  • MTBCP has a Return On Invested Capital of 4.81%. This is amongst the best in the industry. MTBCP outperforms 84.44% of its industry peers.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 4.81%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTBCP Yearly ROA, ROE, ROICMTBCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -20 -40 -60 -80 -100

1.3 Margins

  • Looking at the Operating Margin, with a value of 3.77%, MTBCP is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
  • MTBCP has a worse Gross Margin (38.04%) than 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of MTBCP has declined.
Industry RankSector Rank
OM 3.77%
PM (TTM) N/A
GM 38.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
MTBCP Yearly Profit, Operating, Gross MarginsMTBCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MTBCP Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MTBCP is destroying value.
  • MTBCP has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, MTBCP has a worse debt to assets ratio.
MTBCP Yearly Shares OutstandingMTBCP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 5M 10M
MTBCP Yearly Total Debt VS Total AssetsMTBCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 50M 100M

2.2 Solvency

  • An Altman-Z score of 9.66 indicates that MTBCP is not in any danger for bankruptcy at the moment.
  • MTBCP's Altman-Z score of 9.66 is amongst the best of the industry. MTBCP outperforms 88.89% of its industry peers.
  • MTBCP has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.06, MTBCP belongs to the top of the industry, outperforming 82.22% of the companies in the same industry.
  • MTBCP has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of MTBCP (0.00) is better than 64.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Altman-Z 9.66
ROIC/WACC0.6
WACC8.03%
MTBCP Yearly LT Debt VS Equity VS FCFMTBCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • MTBCP has a Current Ratio of 1.21. This is a normal value and indicates that MTBCP is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of MTBCP (1.21) is worse than 73.33% of its industry peers.
  • A Quick Ratio of 1.19 indicates that MTBCP should not have too much problems paying its short term obligations.
  • MTBCP has a Quick ratio of 1.19. This is in the lower half of the industry: MTBCP underperforms 71.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.19
MTBCP Yearly Current Assets VS Current LiabilitesMTBCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MTBCP Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 56.73% over the past year.
  • Looking at the last year, MTBCP shows a small growth in Revenue. The Revenue has grown by 7.14% in the last year.
  • Measured over the past years, MTBCP shows a very strong growth in Revenue. The Revenue has been growing by 41.63% on average per year.
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%

3.2 Future

  • MTBCP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.25% yearly.
  • The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MTBCP Yearly Revenue VS EstimatesMTBCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MTBCP Yearly EPS VS EstimatesMTBCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. MTBCP Valuation Analysis

4.1 Price/Earnings Ratio

  • MTBCP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MTBCP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTBCP Price Earnings VS Forward Price EarningsMTBCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MTBCP is valued cheaply inside the industry as 84.44% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, MTBCP is valued a bit cheaper than the industry average as 71.11% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 46.5
EV/EBITDA 23.41
MTBCP Per share dataMTBCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MTBCP's earnings are expected to grow with 16.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.89%
EPS Next 3Y16.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MTBCP Dividend Analysis

5.1 Amount

  • No dividends for MTBCP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MTBCP Fundamentals: All Metrics, Ratios and Statistics

CARECLOUD INC - MTBC 11 PERP

NASDAQ:MTBCP (1/9/2023, 8:23:58 PM)

26.9137

-0.08 (-0.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-03
Earnings (Next)03-13
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap409.63M
Revenue(TTM)143.75M
Net Income(TTM)-6.85M
Analysts83.64
Price Target76.1 (182.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-220.54%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.24%
Min EPS beat(2)4.61%
Max EPS beat(2)61.87%
EPS beat(4)4
Avg EPS beat(4)48.06%
Min EPS beat(4)4.61%
Max EPS beat(4)94.23%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.14%
Max Revenue beat(2)-2.32%
Revenue beat(4)1
Avg Revenue beat(4)-1.01%
Min Revenue beat(4)-3.14%
Max Revenue beat(4)2.51%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.43%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.85
P/FCF 46.5
P/OCF 19.3
P/B 3.98
P/tB 34.48
EV/EBITDA 23.41
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)0.58
FCFY2.15%
OCF(TTM)1.39
OCFY5.18%
SpS9.44
BVpS6.76
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 4.81%
ROICexc 4.99%
ROICexgc 43.34%
OM 3.77%
PM (TTM) N/A
GM 38.04%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-3.59%
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.06
Debt/EBITDA 0.03
Cap/Depr 103.98%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.19
Altman-Z 9.66
F-Score4
WACC8.03%
ROIC/WACC0.6
Cap/Depr(3y)81.08%
Cap/Depr(5y)58.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y13.69%
EPS Next 2Y7.89%
EPS Next 3Y16.8%
EPS Next 5Y6.25%
Revenue 1Y (TTM)7.14%
Revenue growth 3Y40.35%
Revenue growth 5Y41.63%
Sales Q2Q%-11.96%
Revenue Next Year0.64%
Revenue Next 2Y1.19%
Revenue Next 3Y3.72%
Revenue Next 5Y2.57%
EBIT growth 1Y261.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1308.1%
EBIT Next 3Y177.57%
EBIT Next 5Y93.09%
FCF growth 1Y213.67%
FCF growth 3Y-21.74%
FCF growth 5YN/A
OCF growth 1Y1553.9%
OCF growth 3Y25.1%
OCF growth 5YN/A

CARECLOUD INC - MTBC 11 PERP / MTBCP FAQ

What is the ChartMill fundamental rating of CARECLOUD INC - MTBC 11 PERP (MTBCP) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MTBCP.


Can you provide the valuation status for CARECLOUD INC - MTBC 11 PERP?

ChartMill assigns a valuation rating of 1 / 10 to CARECLOUD INC - MTBC 11 PERP (MTBCP). This can be considered as Overvalued.


Can you provide the profitability details for CARECLOUD INC - MTBC 11 PERP?

CARECLOUD INC - MTBC 11 PERP (MTBCP) has a profitability rating of 1 / 10.


What is the expected EPS growth for CARECLOUD INC - MTBC 11 PERP (MTBCP) stock?

The Earnings per Share (EPS) of CARECLOUD INC - MTBC 11 PERP (MTBCP) is expected to grow by 13.69% in the next year.